Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00271622 · ClinicalTrials.gov registry record
The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
A clinical trial of Autism and Neuro-Degenerative Disease, sponsored by National Institute of Mental Health (NIMH).
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT00271622: Recruiting study of Autism and Neuro-Degenerative Disease, sponsored by National Institute of Mental Health (NIMH).
NCT00271622 is a study of Autism and Neuro-Degenerative Disease that is actively recruiting participants, run by National Institute of Mental Health (NIMH). The registered enrollment target is 5,000 participants, above the 135-participant average among 104 other Autism trials with a reported enrollment target (3604% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00271622, a study of Autism and Neuro-Degenerative Disease, is actively recruiting participants, sponsored by National Institute of Mental Health (NIMH).
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this protocol is to allow for the careful evaluation of healthy volunteers and individuals with risk for psychiatric disorders or neurodevelopmental disorders, such as autism spectrum disorder for specific protocols at NIH.
Primary Outcome
Screening evaluations such as a psychiatric interview; a diagnostic interview; developmental and/or cognitive testing; ratings of other psychiatric symptoms
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2006-02-27 |
What NCT00271622 shows while recruiting
NCT00271622 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 135-participant average among 104 other Autism trials with a reported enrollment target (3604% higher).
The record links to 4 conditions, with Autism appearing as the primary indexed condition, and to 0 interventions.
NCT00271622 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00271622 about?
NCT00271622 is a clinical study titled "The Neurodevelopmental and Behavioral Phenotyping Screening Protocol". The purpose of this protocol is to allow for the careful evaluation of healthy volunteers and individuals with risk for psychiatric disorders or neurodevelopmental disorders, such as autism spectrum disorder for specific protocols at NIH.
What is the current status of trial NCT00271622?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2006-02-27.
What conditions does trial NCT00271622 study?
This clinical trial studies the following conditions: Autism, Neuro-Degenerative Disease, Neurologic Disorders, Neurobehavioral Manifestation.
Who is sponsoring clinical trial NCT00271622?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00271622 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00271622's enrollment target sits among peer trials
5,000 1st of 104 higher than 104 of 104 other Autism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
-
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
RECRUITING · NA
-
Optimizing Outcomes for Young Autistic Children
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI